// App-Quantinova.ai

2643 : Discovery and characterization of a selective TrkA inhibitor for the treatment of TrkA-driven cancers

Researchers

Presenter

  • Vijaya G. Tirunagaru

Principal Investigators

  • Kumaragurubaran Nagaswamy

  • Sayan Mitra

  • Srinivas Maddi

  • Ram Sudheer Adluri

  • Hemant Joshi

  • Jang B. Gupta

Medical Centers

  • GVK Biosciences, Hyderabad, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Sarcoma

  • Solid malignancies

Biomarkers

  • Nerve Growth Factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved